Research
2023 – ongoing: FWF – Austrian Science Fund
SENIOPROM - Targeting cellular senescence based on inter-organelle communication, multi-level proteostasis and metabolic control, Project Area Leader, Research group
2022 – ongoing: FWF – Austrian Science Fund
TARGET - TARgeted Gene therapy for Epilepsy Treatment. National research partner in Stand-alone Project Nr. P 35579
2021 – ongoing: FWF – Austrian Science Fund
Computational identification of drug resistance mutations, Principal Investigator Stand-alone Project Nr. P 34376
2021 – 2023: Tyrolean Science Fund
Identifying and overcoming next generation c-Kit inhibitor resistance mutations in cancer therapy.